Skip to main content
Top
Published in: Medical Oncology 1/2001

01-03-2001 | Original Article

The implication of compromised renal function at presentation in myeloma

Similar outcome in patients who receive high-dose therapy: A single-center study of 251 previously untreated patients

Authors: B. Sirohi, Professor R. Powles, J. Mehta, J. Treleaven, N. Raje, S. Kulkarni, C. Rudin, N. Bhagwati, C. Horton, R. Saso, S. Singhal, P. Parikh

Published in: Medical Oncology | Issue 1/2001

Login to get access
Metadata
Title
The implication of compromised renal function at presentation in myeloma
Similar outcome in patients who receive high-dose therapy: A single-center study of 251 previously untreated patients
Authors
B. Sirohi
Professor R. Powles
J. Mehta
J. Treleaven
N. Raje
S. Kulkarni
C. Rudin
N. Bhagwati
C. Horton
R. Saso
S. Singhal
P. Parikh
Publication date
01-03-2001
Publisher
Humana Press
Published in
Medical Oncology / Issue 1/2001
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1385/MO:18:1:39

Other articles of this Issue 1/2001

Medical Oncology 1/2001 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.